Back to AMLX

Amylyx Pharmaceuticals, Inc. 8-K

Accession 0000950170-23-041274

Filing information

CIK
0001658551
Report date
2023-08-10
Filing date
2023-08-10
Form
8-K
Primary document
amlx-20230810.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.